Cargando…
A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan
SARS-CoV-2 is a particularly transmissible virus that causes a severe respiratory disease known as COVID-19. Safe and effective vaccines are urgently needed to combat the COVID-19 pandemic. The receptor-binding domain (RBD) of SARS-CoV-2 spike protein elicits most neutralizing antibodies during vira...
Autores principales: | He, Yunxia, Yu, Weili, Shen, Lijuan, Yan, Wenying, Xiao, Lucheng, Qi, Jinming, Hu, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490959/ https://www.ncbi.nlm.nih.gov/pubmed/36152702 http://dx.doi.org/10.1016/j.ijbiomac.2022.09.180 |
Ejemplares similares
-
Purification and characterization of the receptor‐binding domain of SARS‐CoV‐2 spike protein from Escherichia coli
por: He, Yunxia, et al.
Publicado: (2021) -
Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
por: Liu, Xiaofeng, et al.
Publicado: (2023) -
Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021) -
SARS-CoV-2 sublingual vaccine with RBD antigen and poly(I:C) adjuvant: Preclinical study in cynomolgus macaques
por: Yamamoto, Tetsuro, et al.
Publicado: (2023) -
Thermodynamic analysis of the interactions between human ACE2 and spike RBD of Betacoronaviruses (SARS‐CoV‐1 and SARS‐CoV‐2)
por: Rombel‐Bryzek, Agnieszka, et al.
Publicado: (2022)